Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Lyn Harper-Mozley"'
Autor:
David Michelson, Robert S. Stern, Christopher Randolph, Paul S. Aisen, Craig Shering, Nicole Dupre, Alette M. Wessels, Christopher Lines, James Kost, Bruno Vellas, Lyn Harper Mozley, Pierre N. Tariot, Tiffini Voss, Michael F. Egan, Christine Furtek, Yuki Mukai, John R. Sims, Jeffrey L. Cummings, Scott W. Andersen
Publikováno v:
Alzheimer'sdementia : the journal of the Alzheimer's AssociationREFERENCES. 16(11)
Introduction The APECS and AMARANTH trials showed that beta-secretase (BACE) inhibitors verubecestat and lanabecestat failed to slow cognitive and functional decline in individuals with prodromal or early Alzheimer's disease. Here, the performance on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e7c442b70d759befbd7fc0eb9aa0342
https://pubmed.ncbi.nlm.nih.gov/33049114
https://pubmed.ncbi.nlm.nih.gov/33049114
Autor:
Cyrille Sur, Yuki Mukai, Michael F. Egan, Mercè Boada, Christine Furtek, David Michelson, Bruno Vellas, Tiffini Voss, Pierre N. Tariot, Ying Zhang, Lyn Harper Mozley, Yi Mo, Jeffrey L. Cummings, Paul S. Aisen, James Kost, Erin Mahoney, Wen Li, Christopher H. van Dyck
Publikováno v:
N Engl J Med
Prodromal Alzheimer's disease offers an opportunity to test the effect of drugs that modify the deposition of amyloid in the brain before the onset of dementia. Verubecestat is an orally administered β-site amyloid precursor protein-cleaving enzyme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7d8c86d10a50882c43547ecc2e2e9c
https://pubmed.ncbi.nlm.nih.gov/31340105
https://pubmed.ncbi.nlm.nih.gov/31340105
Autor:
Cyrille Sur, Yi Mo, Paul S. Aisen, Tiffini Voss, Jeffrey L. Cummings, Mike F. Egan, Pierre N. Tariot, James Kost, Bruno Vellas, Yuki Mukai, David Michelson, Erin Mahoney, Christopher H. van Dyck, Christine Furtek, Lyn Harper Mozley
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be9b244dfaed93890649e259ca70238f
https://doi.org/10.1016/j.jalz.2018.06.2415
https://doi.org/10.1016/j.jalz.2018.06.2415
Autor:
Christine Furtek, Cyrille Sur, Christopher Lines, James Kost, Bruno Vellas, Yuki Mukai, David Michelson, Tiffini Voss, Michael F. Egan, Pierre N. Tariot, Paul S. Aisen, Lyn Harper Mozley, Nicole Dupre, Jeffrey L. Cummings, Christopher Randolph
Publikováno v:
Alzheimer's & Dementia. 15:P874-P874
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21b396508fe75a4552d95130ef463826
https://doi.org/10.1016/j.jalz.2019.06.4622
https://doi.org/10.1016/j.jalz.2019.06.4622
Autor:
Michael F. Egan, David Michelson, Regina Gottwald, Duane B. Snavely, Ying Zhang, Xin Zhao, Lyn Harper-Mozley, Christopher Lines
Publikováno v:
Schizophrenia Research. 146:224-230
Background Current antipsychotic treatments have little impact on the cognitive deficits associated with schizophrenia. It has been proposed that agents which promote histamine release may enhance cognition. We evaluated whether the H3 inverse agonis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbe8a49e713c8d41ce4167dd1732f43
https://doi.org/10.1016/j.schres.2013.02.030
https://doi.org/10.1016/j.schres.2013.02.030
Autor:
Yi Mo, Tiffini Voss, Cyrille Sur, Michael F. Egan, Benjamin Newton, Ying Zhang, Lyn Harper Mozley, James Kost, Gregory Klein, Yuki Mukai, Christopher Randolph, Julie Chandler, Teresia Möller, Jerome Barakos, Joyce Suhy
Publikováno v:
Alzheimer's & Dementia. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::104e7c68456859259443c55298473f6f
https://doi.org/10.1016/j.jalz.2016.06.2129
https://doi.org/10.1016/j.jalz.2016.06.2129
Autor:
Julie Chandler, Mark Marsico, James Kost, Lyn Harper Mozley, Wen Li, Tiffini Voss, Michael F. Egan
Publikováno v:
Alzheimer's & Dementia. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa1a250e550d8cde24e4859784194cc7
https://doi.org/10.1016/j.jalz.2016.06.1448
https://doi.org/10.1016/j.jalz.2016.06.1448
Autor:
David Michelson, Christopher Assaid, Nancy Strickler, Erin Mahoney, Kathryn M. Connor, David J. Hewitt, Mirja Hämäläinen, Paulette Ceesay, Donald W. Lewis, Robert Bachman, Eric Pearlman, Nicole Dupre, Lyn Harper Mozley, Tony W. Ho, Christopher Lines
Publikováno v:
Headache: The Journal of Head and Face Pain. 53:104-117
Objective To evaluate the safety/tolerability of rizatriptan in the long-term acute treatment of migraine in pediatric patients. Background Acute migraine treatment options for children are limited. A recent single-attack trial demonstrated that riza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76801702a20c5550af140ec0e03a6508
https://doi.org/10.1111/j.1526-4610.2012.02285.x
https://doi.org/10.1111/j.1526-4610.2012.02285.x
Autor:
Kelley Boyd, Tiffany Williamson, Lyn Harper Mozley, Vicki G. Davis, Alexandra S. Atkins, Tiffini Voss, Kerry Budd-McMahon, Ioan Stroescu, Richard S.E. Keefe
Publikováno v:
Alzheimer's & Dementia. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42146b8ca42151150764faa6421e46b6
https://doi.org/10.1016/j.jalz.2015.08.129
https://doi.org/10.1016/j.jalz.2015.08.129
Autor:
Natasha Lowery, Lauren Giovanni, Lyn Harper Mozley, Steven E. Arnold, Warren B. Bilker, Raquel E. Gur, Paul J. Moberg
Publikováno v:
American Journal of Geriatric Psychiatry. 11:621-628
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79bd71d67b34f852eda54a473787e1ba
https://doi.org/10.1097/00019442-200311000-00006
https://doi.org/10.1097/00019442-200311000-00006